Summary of potential actionable gene alterations.xlsx

This dataset contains summary-level information of potential actionable gene alterations identified in 86 patients with metastatic cancer using FoundationOne® CDx (F1CDx) and Liquid CDx (F1LCDx). Potential actionable gene alterations are defined as gene abnormalities known to be involved in cancer and including alterations that may be targets of investigational therapies (evidence levels A to F, according to national guidelines).<br>

本数据集包含通过FoundationOne® CDx（F1CDx）与Liquid CDx（F1LCDx）检测，在86例转移性癌症患者中鉴定出的潜在可干预基因变异的汇总级信息。其中，潜在可干预基因变异被定义为已知与癌症发生相关的基因异常，同时涵盖可作为试验性治疗靶点的变异（依据国内临床指南划分为A至F级证据）。